Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)
Identifieur interne : 001547 ( Main/Exploration ); précédent : 001546; suivant : 001548Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)
Auteurs : L. A. Baltina [Russie] ; R. M. Kondratenko [Russie] ; L. A. Baltina Jr. [Russie] ; O. A. Plyasunova [Russie] ; A. G. Pokrovskii [Russie] ; G. A. Tolstikov [Russie]Source :
- Pharmaceutical Chemistry Journal [ 0091-150X ] ; 2009-10-01.
English descriptors
- KwdEn :
Abstract
The review is devoted to the problem of creating new antiviral drugs based on glycyrrhizic acid (GA), the major triterpene glycoside extracted from roots of common and Ural licorice (Glycyrrhiza glabra L. and G. uralensis Fisher, respectively). Published data on the natural GA sources, antiviral activity of GA and its derivatives, clinical applications of GA-based drugs, and the properties of GA-containing biologically active nutrient additives are summarized. Possible mechanisms of the antiviral activity of GA and its derivatives are examined. It is shown that chemical modification of GA is a promising way of designing new highly active antiviral drugs for the prophylaxis and treatment of HIV, hepatitis B and C, corona-virus, and herpes simplex virus infections.
Url:
- https://api.istex.fr/ark:/67375/VQC-D1R2WX0Z-D/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089237
DOI: 10.1007/s11094-010-0348-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000422
- to stream Istex, to step Curation: 000389
- to stream Istex, to step Checkpoint: 000129
- to stream Pmc, to step Corpus: 000316
- to stream Pmc, to step Curation: 000316
- to stream Pmc, to step Checkpoint: 000875
- to stream Ncbi, to step Merge: 001749
- to stream Ncbi, to step Curation: 001749
- to stream Ncbi, to step Checkpoint: 001749
- to stream Main, to step Merge: 001549
- to stream Main, to step Curation: 001547
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)</title><author><name sortKey="Baltina, L A" sort="Baltina, L A" uniqKey="Baltina L" first="L. A." last="Baltina">L. A. Baltina</name></author><author><name sortKey="Kondratenko, R M" sort="Kondratenko, R M" uniqKey="Kondratenko R" first="R. M." last="Kondratenko">R. M. Kondratenko</name></author><author><name sortKey="Baltina Jr, L A" sort="Baltina Jr, L A" uniqKey="Baltina Jr L" first="L. A." last="Baltina Jr.">L. A. Baltina Jr.</name></author><author><name sortKey="Plyasunova, O A" sort="Plyasunova, O A" uniqKey="Plyasunova O" first="O. A." last="Plyasunova">O. A. Plyasunova</name></author><author><name sortKey="Pokrovskii, A G" sort="Pokrovskii, A G" uniqKey="Pokrovskii A" first="A. G." last="Pokrovskii">A. G. Pokrovskii</name></author><author><name sortKey="Tolstikov, G A" sort="Tolstikov, G A" uniqKey="Tolstikov G" first="G. A." last="Tolstikov">G. A. Tolstikov</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DCCB5A497C36825C7184502129BE3DA6B854D166</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1007/s11094-010-0348-2</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-D1R2WX0Z-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000422</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000422</idno><idno type="wicri:Area/Istex/Curation">000389</idno><idno type="wicri:Area/Istex/Checkpoint">000129</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000129</idno><idno type="wicri:doubleKey">0091-150X:2009:Baltina L:prospects:for:the</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089237</idno><idno type="RBID">PMC:7089237</idno><idno type="wicri:Area/Pmc/Corpus">000316</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000316</idno><idno type="wicri:Area/Pmc/Curation">000316</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000316</idno><idno type="wicri:Area/Pmc/Checkpoint">000875</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000875</idno><idno type="wicri:Area/Ncbi/Merge">001749</idno><idno type="wicri:Area/Ncbi/Curation">001749</idno><idno type="wicri:Area/Ncbi/Checkpoint">001749</idno><idno type="wicri:doubleKey">0091-150X:2009:Baltina L:prospects:for:the</idno><idno type="wicri:Area/Main/Merge">001549</idno><idno type="wicri:Area/Main/Curation">001547</idno><idno type="wicri:Area/Main/Exploration">001547</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)</title><author><name sortKey="Baltina, L A" sort="Baltina, L A" uniqKey="Baltina L" first="L. A." last="Baltina">L. A. Baltina</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Institute of Organic Chemistry, UfaScientific Center, Russian Academy of Sciences, Ufa, Bashkortostan</wicri:regionArea><wicri:noRegion>Bashkortostan</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Russie</country></affiliation></author><author><name sortKey="Kondratenko, R M" sort="Kondratenko, R M" uniqKey="Kondratenko R" first="R. M." last="Kondratenko">R. M. Kondratenko</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Bashkir State Medical University, Ufa, Bashkortostan</wicri:regionArea><wicri:noRegion>Bashkortostan</wicri:noRegion></affiliation></author><author><name sortKey="Baltina Jr, L A" sort="Baltina Jr, L A" uniqKey="Baltina Jr L" first="L. A." last="Baltina Jr.">L. A. Baltina Jr.</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Institute of Organic Chemistry, UfaScientific Center, Russian Academy of Sciences, Ufa, Bashkortostan</wicri:regionArea><wicri:noRegion>Bashkortostan</wicri:noRegion></affiliation></author><author><name sortKey="Plyasunova, O A" sort="Plyasunova, O A" uniqKey="Plyasunova O" first="O. A." last="Plyasunova">O. A. Plyasunova</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>State Research Center of Virology and Biotechnology Vector, Kol’tsovo, Novosibirsk Oblast</wicri:regionArea><wicri:noRegion>Novosibirsk Oblast</wicri:noRegion></affiliation></author><author><name sortKey="Pokrovskii, A G" sort="Pokrovskii, A G" uniqKey="Pokrovskii A" first="A. G." last="Pokrovskii">A. G. Pokrovskii</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>State Research Center of Virology and Biotechnology Vector, Kol’tsovo, Novosibirsk Oblast</wicri:regionArea><wicri:noRegion>Novosibirsk Oblast</wicri:noRegion></affiliation></author><author><name sortKey="Tolstikov, G A" sort="Tolstikov, G A" uniqKey="Tolstikov G" first="G. A." last="Tolstikov">G. A. Tolstikov</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Institute of Organic Chemistry, UfaScientific Center, Russian Academy of Sciences, Ufa, Bashkortostan</wicri:regionArea><wicri:noRegion>Bashkortostan</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Pharmaceutical Chemistry Journal</title><title level="j" type="abbrev">Pharm Chem J</title><idno type="ISSN">0091-150X</idno><idno type="eISSN">1573-9031</idno><imprint><publisher>Springer US; http://www.springer-ny.com</publisher><pubPlace>Boston</pubPlace><date type="published" when="2009-10-01">2009-10-01</date><biblScope unit="volume">43</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="539">539</biblScope><biblScope unit="page" to="548">548</biblScope></imprint><idno type="ISSN">0091-150X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0091-150X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>antiviral activity</term><term>antiviral drugs</term><term>biologically active nutrient additives</term><term>glycyrrhizic acid</term><term>licorice root</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The review is devoted to the problem of creating new antiviral drugs based on glycyrrhizic acid (GA), the major triterpene glycoside extracted from roots of common and Ural licorice (Glycyrrhiza glabra L. and G. uralensis Fisher, respectively). Published data on the natural GA sources, antiviral activity of GA and its derivatives, clinical applications of GA-based drugs, and the properties of GA-containing biologically active nutrient additives are summarized. Possible mechanisms of the antiviral activity of GA and its derivatives are examined. It is shown that chemical modification of GA is a promising way of designing new highly active antiviral drugs for the prophylaxis and treatment of HIV, hepatitis B and C, corona-virus, and herpes simplex virus infections.</div></front></TEI><affiliations><list><country><li>Russie</li></country></list><tree><country name="Russie"><noRegion><name sortKey="Baltina, L A" sort="Baltina, L A" uniqKey="Baltina L" first="L. A." last="Baltina">L. A. Baltina</name></noRegion><name sortKey="Baltina Jr, L A" sort="Baltina Jr, L A" uniqKey="Baltina Jr L" first="L. A." last="Baltina Jr.">L. A. Baltina Jr.</name><name sortKey="Baltina, L A" sort="Baltina, L A" uniqKey="Baltina L" first="L. A." last="Baltina">L. A. Baltina</name><name sortKey="Kondratenko, R M" sort="Kondratenko, R M" uniqKey="Kondratenko R" first="R. M." last="Kondratenko">R. M. Kondratenko</name><name sortKey="Plyasunova, O A" sort="Plyasunova, O A" uniqKey="Plyasunova O" first="O. A." last="Plyasunova">O. A. Plyasunova</name><name sortKey="Pokrovskii, A G" sort="Pokrovskii, A G" uniqKey="Pokrovskii A" first="A. G." last="Pokrovskii">A. G. Pokrovskii</name><name sortKey="Tolstikov, G A" sort="Tolstikov, G A" uniqKey="Tolstikov G" first="G. A." last="Tolstikov">G. A. Tolstikov</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001547 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001547 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:DCCB5A497C36825C7184502129BE3DA6B854D166
|texte= Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)
}}
| This area was generated with Dilib version V0.6.33. |  |